Literature DB >> 8418776

Induction of hepatocyte lipopolysaccharide binding protein in models of sepsis and the acute-phase response.

D A Geller1, P H Kispert, G L Su, S C Wang, M Di Silvio, D J Tweardy, T R Billiar, R L Simmons.   

Abstract

Lipopolysaccharide binding protein (LBP) is a serum glycoprotein that complexes with lipopolysaccharide (LPS) to facilitate macrophage response to endotoxin. To determine the conditions that stimulate LBP production in vivo, we measured the induction of LBP in models of inflammation produced by LPS, Corynebacterium parvum, and turpentine injection. Plasma aspartate aminotransferase and alanine aminotransferase concentrations and hepatocyte fibrinogen synthesis were elevated in all models. Northern blot analysis revealed 17-, 14-, and 20-fold upregulation of hepatocyte LBP mRNA following treatment with LPS, C parvum, and turpentine, respectively. Peritoneal macrophage interleukin 6 and tumor necrosis factor production following endotoxin stimulation was augmented by cultured hepatocyte supernatants, suggesting increased LBP synthesis in these groups. The results show that LBP mRNA is induced during hepatic inflammation and suggest that LBP is an acute-phase protein important in regulating the in vivo response to endotoxin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418776     DOI: 10.1001/archsurg.1993.01420130026005

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  14 in total

1.  Changes in endotoxin-binding proteins during major elective surgery: important role for soluble CD14 in regulation of biological activity of systemic endotoxin.

Authors:  N Hiki; D Berger; M A Dentener; Y Mimura; W A Buurman; C Prigl; M Seidelmann; E Tsuji; M Kaminishi; H G Beger
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

2.  The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis.

Authors:  Tamer Sallam; Ayaka Ito; Xin Rong; Jason Kim; Caroline van Stijn; Brian T Chamberlain; Michael E Jung; Lily C Chao; Marius Jones; Thomas Gilliland; XiaoHui Wu; Grace L Su; Rajendra K Tangirala; Peter Tontonoz; Cynthia Hong
Journal:  J Lipid Res       Date:  2014-03-26       Impact factor: 5.922

3.  CD14 and lipopolysaccharide binding protein expression in a rat model of alcoholic liver disease.

Authors:  G L Su; A Rahemtulla; P Thomas; R D Klein; S C Wang; A A Nanji
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

4.  STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo.

Authors:  Ryotaro Sakamori; Tetsuo Takehara; Tomohide Tatsumi; Minoru Shigekawa; Hayato Hikita; Naoki Hiramatsu; Tatsuya Kanto; Norio Hayashi
Journal:  J Gastroenterol       Date:  2009-12-01       Impact factor: 7.527

5.  Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis.

Authors:  Armando Guerra Ruiz; Fernando Casafont; Javier Crespo; Amalia Cayón; Marta Mayorga; Angel Estebanez; José Carlos Fernadez-Escalante; Fernando Pons-Romero
Journal:  Obes Surg       Date:  2007-10       Impact factor: 4.129

6.  Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia.

Authors:  S Liu; L S Khemlani; R A Shapiro; M L Johnson; K Liu; D A Geller; S C Watkins; S M Goyert; T R Billiar
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

7.  Lipopolysaccharide-binding protein: a valuable biomarker in the differentiation between periprosthetic joint infection and aseptic loosening?

Authors:  Max J Friedrich; Thomas M Randau; Matthias D Wimmer; Ben Reichert; Dominik Kuberra; Birgit Stoffel-Wagner; Dieter C Wirtz; Sascha Gravius
Journal:  Int Orthop       Date:  2014-05-15       Impact factor: 3.075

8.  Role of lipopolysaccharide (LPS), interleukin-1, interleukin-6, tumor necrosis factor, and dexamethasone in regulation of LPS-binding protein expression in normal hepatocytes and hepatocytes from LPS-treated rats.

Authors:  Y Wan; P D Freeswick; L S Khemlani; P H Kispert; S C Wang; G L Su; T R Billiar
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

9.  Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation.

Authors:  Jason W Chien; Michael J Boeckh; John A Hansen; Joan G Clark
Journal:  Blood       Date:  2007-12-03       Impact factor: 22.113

10.  Lipopolysaccharide binding protein (L.B.P.)--an inflammatory marker of prognosis in the acute appendicitis.

Authors:  C Brănescu; D Şerban; C Şavlovschi; A M Dascălu; A Kraft
Journal:  J Med Life       Date:  2012-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.